| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD7762 | GDSC1000 | pan-cancer | AAC | -0.076 | 0.02 |
| mRNA | RITA | CTRPv2 | pan-cancer | AAC | -0.083 | 0.02 |
| mRNA | JNK Inhibitor VIII | GDSC1000 | pan-cancer | AAC | -0.082 | 0.02 |
| mRNA | PIK-93 | CTRPv2 | pan-cancer | AAC | -0.081 | 0.02 |
| mRNA | B02 | CTRPv2 | pan-cancer | AAC | -0.084 | 0.02 |
| mRNA | PIK-93 | GDSC1000 | pan-cancer | AAC | -0.067 | 0.02 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | -0.11 | 0.02 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | -0.11 | 0.02 |
| mRNA | BRD-K13999467 | CTRPv2 | pan-cancer | AAC | -0.083 | 0.03 |
| mRNA | AZD-7545 | CTRPv2 | pan-cancer | AAC | -0.084 | 0.03 |